FNDC5 and fatty liver disease: Irisin, a myokine that promotes energy expenditure [23], has also been shown to improve hepatic steatosis by activating AMP-activated protein kinase and by inhibiting transcription of sterol regulatory element-binding transcription factor 2 in hepatocytes [24].